• Every child in NZ <18 years of age is funded for NIS vaccines regardless of immigration status.
• Some NIS vaccines are funded for people eligible for NZ funded healthcare over 18 years of age.
• People immunised overseas are transferred to the current NZ NIS and, if required, an age appropriate catch-up programme is planned.
• Identify documented antigens previously received and at what age (Note: HepB birth doses do not count as part of primary course).
• Do not repeat prior doses or restart a vaccine course, even if significant time has elapsed.
• Plan a catch-up immunisation schedule to protect as soon as possible.
• Ensure a minimum 4-week (28 day) interval between vaccines of same antigen, except 8-week interval between first two doses of PCV and MenB and final two doses of HepB should be at least six months apart.
• When giving different live vaccines, give on same day or minimum 4-week (28 day) interval.
• DTaP-IPV-HepB/Hib (Infanrix®-hexa) and DTaPIPV (Infanrix®-IPV) can be used up to 10 years of age.
• For at risk or special groups eg pneumococcal or BCG, refer to Immunisation Handbook.
3 months to under 12 months
12 months to under 5 years
5 years to under 18 years
18 years and over
DTaP-IPV-HepB/Hib + PCV + MenB + RV*
DTaP-IPV-HepB/Hib + RV*
DTaP-IPV-HepB/Hib + PCV + MenB
DTaP-IPV-HepB/Hib
* RV: 1st dose before 15 weeks, 2nd dose before 25 weeks.
Minimum antigens to receive by 12 months:
3 DTaP 3 IPV 3 HepB 3 Hib 2 PCV 2 MenB 2RV
DTaP-IPV-HepB/Hib + PCV** + MenB + MMR
DTaP-IPV-HepB/Hib* + MMR + VV
DTaP-IPV-HepB/Hib*+ PCV** + MenB***
DTaP-IPV-HepB/Hib*
* Hib; one dose only required 12 months to under 5 years. There are no safety concerns re any extra doses of Hib or HepB. If parental concern, can use separate DTaP-IPV and HepB or Hib.
* If a 4th dose of tetanus containing vaccine was given overseas under age 3 years, a 4-year dose is still recommended.
** If two doses of PCV given <12 months a booster of PCV is needed after 12 months of age. If one dose of PCV given <12 months or two doses not 8 weeks apart, two doses of PCV are needed 8 weeks apart.
*** If 1st dose of MenB given between 12 and 23 months a booster dose of MenB can be given 12-24 months after 2nd dose. If 1st dose of MenB given <12 months a booster dose is recommended at age ≥12 months or a minimum of 6 months after 2nd dose, whichever is later.
# If a 4th dose of tetanus containing vaccine was given overseas under age 3 years, a 4-year dose is still recommended.
3 or 4 DTaP 3 or 4 IPV 3 or 4 HepB
2 PCV 2 MMR 1 VV 1 Hib 2 or 3 MenB
DTaP-IPV-HepB/Hib* + MMR + VV**
DTaP-IPV-HepB/Hib* + MMR
DTaP-IPV-HepB/Hib*
DTaP-IPV-HepB/Hib*
* Hib and PCV vaccinations are not required over age 5 years.
* No safety concerns re extra Hib, Hep B or IPV doses when using DTaP-IPV-HepB/Hib or DTaP-IPV. If parental concern, can use Tdap as an alternative over age of 7 years plus separate HepB and IPV.
**VV for children born after1 April 2016 who have not had chicken pox disease.
4 DTaP 3 IPV 3 or 4 HepB 2 MMR 1VV
Tdap + IPV + MMR + HepB*
Tdap + IPV + MMR + HepB*
Tdap + IPV
Tdap + HepB* + VV**
* HepB – 3 HepB at 0, 1 and 6 months, or alternative for 11 - 15 year olds – 2 dose HepB at 0 and 6 months.
** Varicella vaccine if eligible
From age 12 years
Include HPV vaccine - number of doses and spacing dependent on age – see notes below.
4 Tdap 3 IPV 2 MMR 1 W 2 or 3 HepB
Tdap + IPV + MMR
Tdap + IPV + MMR
Tdap + IPV
3 HPV (eligible if 1st dose given before 27 years standard schedule 0, 2, 6 months)
Antigen requirements
3 Tdap 3 IPV 2 MMR 3 HPV
Refer to notes below
Tdap
Every pregnancy from 2nd trimester
Adult boosters offered from 45 & 65 years of age
Influenza
Annually, every pregnancy, aged 65y and over, and those 6 months of age in defined risk groups
(see more on influenza.org.nz)
MMR
Two documented doses over 12 months of age, with minimum 4-week interval required, for those born since 1 Jan 1969.
HPV
Aged 11 - 14 years, 2 doses given at least 5 months apart, even if 2nd dose given over 15 years
Aged 15 - 27 years, standard schedule 0, 2, 6 months. If shortened schedule necessary, minimum 4 weeks between dose 1 and 2 and 12 weeks between dose 2 and 3.
MenB
For children under 5 years, the required number and timing of doses is based on the age at which the child received their first dose. Timing of boosters for children under 24 months will vary depending on timing of completed primary course, see appendix 2 in IHB. Children who receive dose 1 ≥24 months require just two doses, separated by 8 weeks.
Varicella eligibility
Born on or after 1 April 2016
Turned 11 years on or after 1 July 2017 (if non-immune)
Shingrix eligibility
65 years, 2 doses given 0 and 2-6 months apart. Second dose funded at 66 years if first dose given at 65 years.